Cue Biopharma, Inc. financial data

Symbol
CUE on Nasdaq
Location
40 Guest Street, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 153 % -37.5%
Debt-to-equity 129 % +65.7%
Return On Equity -272 % -73.7%
Return On Assets -119 % -35%
Operating Margin -538 % -12.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.7M shares +24.3%
Common Stock, Shares, Outstanding 77.8M shares +29.2%
Entity Public Float 59.9M USD -61.2%
Common Stock, Value, Issued 78K USD +30%
Weighted Average Number of Shares Outstanding, Basic 101M shares +96.9%
Weighted Average Number of Shares Outstanding, Diluted 101M shares +96.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7.1M USD -25.5%
Research and Development Expense 28.4M USD -29%
General and Administrative Expense 16.8M USD +10.8%
Operating Income (Loss) -38.2M USD +16.5%
Nonoperating Income (Expense) 480K USD -55.8%
Net Income (Loss) Attributable to Parent -37.7M USD +15.5%
Earnings Per Share, Basic 0 USD/shares +52.7%
Earnings Per Share, Diluted 0 USD/shares +52.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.7M USD -63.9%
Accounts Receivable, after Allowance for Credit Loss, Current 387K USD -87.7%
Assets, Current 25.8M USD -30.7%
Property, Plant and Equipment, Net 307K USD -46.1%
Operating Lease, Right-of-Use Asset 4.6M USD +14.1%
Other Assets, Noncurrent 96K USD -11.1%
Assets 31.6M USD -29.4%
Accounts Payable, Current 2.35M USD -63.7%
Accrued Liabilities, Current 1.87M USD -41.5%
Liabilities, Current 15.5M USD -7.54%
Operating Lease, Liability, Noncurrent 2.68M USD +102%
Liabilities 18.4M USD -5.38%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1K USD
Retained Earnings (Accumulated Deficit) -370M USD -11.3%
Stockholders' Equity Attributable to Parent 13.2M USD -47.8%
Liabilities and Equity 31.6M USD -29.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.17M USD +16.5%
Net Cash Provided by (Used in) Financing Activities -1M USD -142%
Net Cash Provided by (Used in) Investing Activities -150K USD -173%
Common Stock, Shares Authorized 300M shares +200%
Common Stock, Shares, Issued 77.8M shares +29.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.32M USD -24.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 90K USD -56.9%
Deferred Tax Assets, Valuation Allowance 94M USD +11.8%
Deferred Tax Assets, Gross 95.2M USD +10.9%
Operating Lease, Liability 4.72M USD +11.7%
Depreciation 362K USD -22%
Payments to Acquire Property, Plant, and Equipment 150K USD +173%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.7M USD +15.5%
Lessee, Operating Lease, Liability, to be Paid 5.3M USD +19.9%
Property, Plant and Equipment, Gross 3.9M USD -12.7%
Operating Lease, Liability, Current 2.03M USD -29.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.23M USD -20.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 630K USD -21.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +67.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 586K USD +194%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.88M USD +130%
Deferred Tax Assets, Operating Loss Carryforwards 58.1M USD +8.89%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.14M USD +7.21%
Lessee, Operating Lease, Liability, to be Paid, Year Four 559K USD
Operating Lease, Payments 709K USD +139%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.21M USD -32.2%
Share-based Payment Arrangement, Expense 5.7M USD -22.6%
Interest Expense 100K USD -14.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%